Powering global life sciences companies
Reinventing data-driven research
Making the best decisions means looking at all the facts – a near-impossible task in our era of information overload. To fix this, we are building the next generation of machine learning software. Powered by generative AI, our algorithms analyze key information sources and provide comprehensive, factual answers for even your most complex queries.
We help decision makers worldwide focus on the work that really matters.
Meet Reliant Tabular
AI software for your everyday research
Use our distributed algorithms to analyze dozens of information sources, all at once.
Our interface blends chatbot ease with the precision of tables and diagrams for an effortlessly efficient experience.
Our specialized language models provide answers up to ten times faster than general-purpose solutions.
We deploy proprietary data lineage methods to support your business insights. No hallucinations.
Reliant for Biopharma
Our software analyzes documents up to 126x faster than a trained research assistant. Get answers in seconds, not hours.
The average researcher misses one out of ten key insights from any given information source. Our comprehensive data extraction algorithms surfaces hard-to-find insights and makes it easy to cross-reference supporting evidence.
We provide easy access to biomedical data providers and make it seamless to combine these with your own sources.
Less time spent finding facts means more time to put together high-quality analyses, leading to better outcomes and ROI.
- Trial design
- Biomarker identification
- Site identification
- Enrollment optimization
Disease landscape analysis
- Treatment algorithms
- Patient journey
- Patient segmentation
- Competitive analysis
- Analog identification
- HTA reasoning
- Systematic literature reviews
- Global value dossiers (GVDs)
Led by renowned researchers
We are scientists. Builders. Entrepreneurs. We spearheaded many of AI’s most impactful applications. We led teams at Google, DeepMind, and EY Parthenon. We now bridge cutting-edge AI research and the biopharma industry.
We believe that the transformative impact of generative AI will be only realized by those willing to take on the world’s biggest information challenges. To make this future come true, we deploy our longstanding expertise in reinforcement learning and natural language processing.
Our founding team
Chief Executive Officer – Karl Moritz Hermann
Chief Scientific Officer – Marc G. Bellemare
Head of Commercial – Richard Schlegel